Turkish Abstract Abstract Free Full Text English Similar Articles Mail to Author

¹Associate Prof., MD., Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey
²Prof. MD., Private Practice, Ankara, Turkey DOI : 10.37845/ret.vit.2020.29.30 Since several cases of pneumonia of unknown microbial origin that were detected at Wuhan City, China in late December 2019, entire countries are under lockdown to limit the spread of the virus. During this emergency state, accessibility to healthcare services is an increasing challenge. Uveitis population is one of the vulnerable groups which need constant follow-up and guidance because the nature course of their disease. It has been particularly concerning for the patients taking immunomodulatory treatment. Herein, we summarize strategies and preventive measure in the management of uveitis patients during COVID-19. Keywords : Uveitis, Immunomodulatory treatment, Pandemia, COVID-19, SARS-CoV-2